T Priestman

712 total citations
8 papers, 605 citations indexed

About

T Priestman is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, T Priestman has authored 8 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 1 paper in Pathology and Forensic Medicine and 1 paper in Dermatology. Recurrent topics in T Priestman's work include Cancer Treatment and Pharmacology (3 papers), Cancer survivorship and care (2 papers) and HER2/EGFR in Cancer Research (1 paper). T Priestman is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Cancer survivorship and care (2 papers) and HER2/EGFR in Cancer Research (1 paper). T Priestman collaborates with scholars based in United Kingdom. T Priestman's co-authors include Peter Maguire, Peter J. Selby, Marianna K. Baum, John Forbes, Sarah Damery, Sandra Jo Wilson, Sayeed Haque, L E Hughes, David Webster and R. Rampling and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Cancer Immunology Immunotherapy.

In The Last Decade

T Priestman

8 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T Priestman United Kingdom	7	402	206	153	139	121	8	605
Melanie Brooke United Kingdom	7	284 0.7×	129 0.6×	120 0.8×	123 0.9×	64 0.5×	13	492
Neil Love United States	9	353 0.9×	109 0.5×	78 0.5×	78 0.6×	84 0.7×	26	518
Linda Sutton United States	15	475 1.2×	188 0.9×	251 1.6×	91 0.7×	102 0.8×	45	948
Nellie Garcia United States	7	567 1.4×	262 1.3×	186 1.2×	157 1.1×	155 1.3×	11	782
Fatemeh Khaleghi Iran	5	620 1.5×	124 0.6×	77 0.5×	135 1.0×	133 1.1×	7	766
Jennifer Wiernikowski Canada	9	425 1.1×	159 0.8×	238 1.6×	141 1.0×	73 0.6×	11	631
Amy Or Hong Kong	13	400 1.0×	127 0.6×	189 1.2×	310 2.2×	68 0.6×	23	774
Laura Gangeri Italy	12	401 1.0×	169 0.8×	205 1.3×	167 1.2×	98 0.8×	30	872
Anne Kvikstad Norway	10	404 1.0×	237 1.2×	187 1.2×	72 0.5×	112 0.9×	14	675
PN Butow Australia	6	450 1.1×	220 1.1×	157 1.0×	113 0.8×	138 1.1×	13	596

Countries citing papers authored by T Priestman

Since Specialization

Citations

This map shows the geographic impact of T Priestman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Priestman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Priestman more than expected).

Fields of papers citing papers by T Priestman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Priestman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Priestman. The network helps show where T Priestman may publish in the future.

Co-authorship network of co-authors of T Priestman

This figure shows the co-authorship network connecting the top 25 collaborators of T Priestman. A scholar is included among the top collaborators of T Priestman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Priestman. T Priestman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wilson, Sandra Jo, et al.. (2010). How do the information needs of cancer patients differ at different stages of the cancer journey? A cross-sectional survey. JRSM Short Reports. 1(4). 1–10. 85 indexed citations

2.

Maguire, Peter, et al.. (1994). Screening for anxiety and depression in cancer patients: the effects of disease and treatment. European Journal of Cancer. 30(1). 37–40. 364 indexed citations

3.

Priestman, T, et al.. (1993). A phase II evaluation of human lymphoblastoid interferon (Wellferon) in relapsed high grade malignant glioma. Clinical Oncology. 5(3). 165–168. 9 indexed citations

4.

Ashford, Richard, et al.. (1986). Combining interferon with cytotoxic chemotherapy in patients with advanced breast cancer. Cancer Immunology Immunotherapy. 23(3). 217–9. 3 indexed citations

5.

Baum, Marianna K., et al.. (1980). A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast.. PubMed. Suppl 1. 223–6. 55 indexed citations

6.

Webster, David, et al.. (1979). Effect of treatment on the immunological status of women with advanced breast cancer. British Journal of Cancer. 39(6). 676–680. 17 indexed citations

7.

Priestman, T, et al.. (1978). Treatment and survival on advanced breast cancer.. BMJ. 2(6153). 1673–1674. 22 indexed citations

8.

Priestman, T, et al.. (1977). Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.. BMJ. 1(6071). 1248–1250. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact